1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-Phosphocholine
(Synonyms: C16(plasm)-18:2-PC; 1-1(Z)-Hexadecenyl-2-Linoleoyl-sn-glycero-3-PC; 1-1(Z)-Hexadecenyl-2-(9Z,12Z)-Octadecadienoyl-sn-glycero-3-Phosphocholine; 16:0p/18:2-PC; PC(P-16:0/18:2); PlgPC 16:0/18:2) 目录号 : GC927131-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine is a plasmalogen that contains 1(Z)-hexadecenoic acid and linoleic acid at the sn-1 and sn-2 positions, respectively.
Cas No.:204983-73-3
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine is a plasmalogen that contains 1(Z)-hexadecenoic acid and linoleic acid at the sn-1 and sn-2 positions, respectively. It inhibits lead-induced decreases in viability and lead-induced increases in reactive oxygen species (ROS) and oxidized phospholipids in HepG2 hepatocytes. Serum levels of 1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine are decreased in dogs with myxomatous mitral valve disease when fed a diet including medium chain triglycerides, fish oil, carnitine precursors, magnesium, and antioxidants.
| Cas No. | 204983-73-3 | SDF | |
| 别名 | C16(plasm)-18:2-PC; 1-1(Z)-Hexadecenyl-2-Linoleoyl-sn-glycero-3-PC; 1-1(Z)-Hexadecenyl-2-(9Z,12Z)-Octadecadienoyl-sn-glycero-3-Phosphocholine; 16:0p/18:2-PC; PC(P-16:0/18:2); PlgPC 16:0/18:2 | ||
| 化学名 | (7R,17Z,20Z)-7-[[(1Z)-1-hexadecen-1-yloxy]methyl]-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5,8-trioxa-4-phosphahexacosa-17,20-dien-1-aminium, inner salt, 4-oxide | ||
| Canonical SMILES | O=P(OCC[N+](C)(C)C)([O-])OC[C@H](OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)CO/C=C\CCCCCCCCCCCCCC | ||
| 分子式 | C42H80NO7P | 分子量 | 742.075762 |
| 溶解度 | Ethanol: Soluble | 储存条件 | -20°C |
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.3476 mL | 6.7379 mL | 13.4757 mL |
| 5 mM | 269.5 μL | 1.3476 mL | 2.6951 mL |
| 10 mM | 134.8 μL | 673.8 μL | 1.3476 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet